Peripheral Dopamine Suppression and Elevated Cystatin C in Early Diabetic Nephropathy in Spontaneously Diabetic Rats.
自發性糖尿病大鼠早期糖尿病腎病中的外周多巴胺抑制與升高的Cystatin C。
Am J Physiol Renal Physiol 2024-08-01
Sitagliptin Mitigates Diabetic Nephropathy in a Rat Model of Streptozotocin-Induced Type 2 Diabetes: Possible Role of PTP1B/JAK-STAT Pathway.
Sitagliptin 在一個 Streptozotocin-誘導的第2型糖尿病大鼠模型中緩解糖尿病腎病變:PTP1B/JAK-STAT 途徑的可能作用。
Int J Mol Sci 2023-04-15
A Transcriptome Array-Based Approach to Link SGLT-2 and Intrarenal Complement C5 Synthesis in Diabetic Nephropathy.
一種基於轉錄體陣列的方法,將 SGLT-2 與糖尿病腎病中腎內補體 C5 合成聯繫起來。
Int J Mol Sci 2023-12-20
DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson's disease.
DPP-4 抑制劑 sitagliptin 和 PF-00734,200 在大鼠 6-OHDA 帕金森氏症模型中緩解多巴胺能神經退化、神經炎症和行為障礙。
Geroscience 2024-04-02
Dapagliflozin restores autophagy and attenuates apoptosis via the AMPK/mTOR pathway in diabetic nephropathy rats and high glucose-induced HK-2 cells.
Dapagliflozin 透過 AMPK/mTOR 路徑恢復自噬並減少糖尿病腎病大鼠及高葡萄糖誘導的 HK-2 細胞中的凋亡。
Int Urol Nephrol 2024-07-29
Chronic endothelial dopamine receptor stimulation improves endothelial function and hemodynamics in autosomal dominant polycystic kidney disease.
自體顯性多囊腎病中,慢性內皮多巴胺受體刺激改善內皮功能和血流動力學。
Kidney Int 2024-08-31